Virobay, Xenon set IPO terms

Virobay Inc. (Menlo Park, Calif.) and Xenon Pharmaceuticals Inc. (Burnaby, B.C.) both set terms for their proposed IPOs on NASDAQ

Virobay plans to sell 3.8 million shares at $12-$14. At $13, Virobay would raise $50 million and be valued at $169 million. Piper Jaffray; JMP Securities; Cantor Fitzgerald; and Summer Street Research Partners are underwriters. ...